Publications

Every year, the department publishes a number of articles and conference proceedings. A non-inclusive list are given for each year recorded. Missing materials can be found, for example, in the International Journal of Radiation Oncology (aka the “red journal”), the International Journal of Medical Physics Research and Practice, or elsewhere. See here for more leads.

Last updated 20 March 2024.

2024 Publications

  • Justin Poon, Richard B. Thompson, Marc W. Deyell, Devin Schellenberg, Haley Clark, Stefan Reinsberg, and Steven Thomas. Analysis of left ventricle regional myocardial motion for cardiac radioablation. JACMP. 2024;e14333. https://doi.org/10.1002/acm2.14333
  • Justin Poon, Richard Thompson, Marc W Deyell, Devin Schellenberg, Kirpal Singh Kohli and Steven Thomas. Left ventricle segment-specific motion assessment for cardiac-gated radiosurgery. Biomedical Physics & Engineering Express.10(2024) 025040. https://doi.org/10.1088/2057-1976/ad29a4
  •  Robert Olson et. al. including Alanah Bergman. Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET. BMC Cancer. 2024; 24:171. https://doi.org/10.1186/s12885-024-11905-7
  • E.M Cruz-Lim et. al. including Alanah Bergman and Ante Mestrovic. Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II Trial. 36:141-147 (2024). https://doi.org/10.1016/j.clon.2024.01.007
  • E.M. Cruz-Lim et. al. including Alanah Bergman and Ante Mestrovic. Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial. Clin. Oncol. 36:148-156 (2024). https://doi.org/10.1016/j.clon.2023.11.041
  • Aria Malhotra, Emilie E. Carpentier, Sheri Grahame,  Elisa K. Chan, Alan Nichol, and Cheryl Duzenli. Toward a Skin Dose-Area Metric Predictive of Moist Desquamation Using In Vivo Skin Dosimetry and Skin Assessments. Adv. Rad. Onc. 2024;9(1):101318. https://doi.org/10.1016/j.adro.2023.101318.
  • Emilie E. Carpentier, Ronan L. McDermott, Marie-Laure A. Camborde, Tania Karan, Alanah M. Bergman, Ante Mestrovic. Four-dimensional treatment planning strategies for dynamic tumor tracking. JACMP. 2024;e14269. https://doi.org/10.1002/acm2.14269
  • S Baker, Lechner L, M Liu, J Chang, E Cruz-Lim, B Mou, W Jiang, A Bergman, D Schellenberg, A Alexander, T Berrang, A Bang, N Chng, Q Matthews, H Carolan, F Hsu, S Miller, S Atrchian, E Chan, C Ho, I Mohamed, A Lin, V Huang, A Mestrovic, D Hyde, C Lund, H Pai, B Valev, S Lefresne, G Arbour, I Yu, S Tyldesley and RA Olson. Upfront versus Delayed Systemic Therapy in Patients with Oligometastatic Cancer Treated with Stereotactic Ablative Radiotherapy on the Phase II SABR-5 Trial. IJROBP. 2024:118(5) 1497-1506. https://doi.org/10.1016/j.ijrobp.2024.01.008

2023 Publications

  • Marco Carlone, Wayne Beckham, Cheryl Duzenli, Kirpal Kohli and Scott Tyldesley. Linear accelerator maintenance cost analysis. JACMP. 2023;e14246. https://doi.org/10.1002/acm2.14246
  • Abraham Alexander, Issabelle Gagne, Gaurav Bahl, David Kim, Ante Mestrovic, Allison Ye, Winkle Kwan and Samar Hejazi. Late Toxicity of Prostate Ultrahypofractionated Radiotherapy Compared to Moderate Hypofractionation in a Randomized Trial. IJROBP. IN PRESS. https://doi.org/10.1016/j.ijrobp.2023.11.048
  • Maryam Rostamzadeh, Steven Thomas, Marie-Laure Camborde, Tania Karan, Mitchell Liu, Roy Ma, Ante Mestrovic, Bradford Gill, Isaac Tai, Alanah Bergman. Markerless dynamic tumor tracking (MDTT) radiotherapy using diaphragm as a surrogate for liver targets. JACMP. 2023. e14161. https://doi.org/10.1002/acm2.14161
  • Emilie E Carpentier, Ronan L Mcdermott, Shiqin Su, Maryam Rostamzadeh, I Antoniu Popescu, Alanah M Bergman, Ante Mestrovic. Monte Carlo Modeling of Dynamic Tumor Tracking on a Gimbaled Linear Accelerator. J Med Phys. 2023; 48:50-8. doi.org/10.4103/jmp.jmp_108_22
  • Tenzin Kunkyab, Benjamin Mou, Andrew Jirasek, Christina Haston, Jeff Andrews, Steven Thomas and Derek E Hyde. Radiomic analysis for early differentiation of lung cancer recurrence from fibrosis in patients treated with lung stereotactic ablative radiotherapy. Phys Med Bio. 2023. 68:165015 doi.org/10.1088/1361-6560/acd431.
  • Maryam Rostamzadeh, Kurt Luchka, Roy Ma, Mitchell Liu, Emma Dunne, Marie-Laure Camborde, Tania Karan, Ante Mestrovic and Alanah Bergman. In-vivo quality assurance of dynamic tumor tracking (DTT) for liver SABR using EPID images. JACMP. 2023;e13969. https://doi.org/10.1002/acm2.13969
  • Shiqin Su, Parmveer Atwal and I Antoniu Popescu. Monte Carlo based continuous aperture optimization for VMAT on conventional and MR-linacs: A proof of concept. Medical Physics. 2023; 1-14. https://doi.org/10.1002/mp.16358
  • Reno Eufemon Cereno, Benjamin Moua, Sarah Baker, Nick Chng, Gregory Arbour, Alanah Bergman, Mitchell Liu, Devin Schellenberg, Quinn Matthews, Vicky Huang, Ante Mestrovic, Derek Hyde, Abraham Alexander, Hannah Carolan, Fred Hsu, Stacy Miller, Siavash Atrchian, Elisa Chan, Clement Ho, Islam Mohamed, Angela Lin, Tanya Berrang, Andrew Bang, Will Jiang, Chad Lund, Howard Pai, Boris Valev, Shilo Lefresne, Scott Tyldesley, and Robert A. Olson. Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial. Radiotherapy and Oncology. 182:109576 (2023).https://doi.org/10.1016/j.radonc.2023.109576.
  • Derek John Cappon, Susanna Fang, Kendall Berry, Gina Capone, Gina L. Carlton, Mario Chrétien, John Gough, Jacob Kamen, Anne Khoorshed, Andy Miller, Stephen Nelli, M. Peter Petric, Frank Tourneur, and Josip J. Zic. Clinical best practices for radiation safety during Lutetium-177 therapy. Health Physics. 124(2):139-46 (2023). https://doi.org/10.1097/HP.0000000000001644.

2022 Publications

  • Roberto Fedrigo, Dan J. Kadrmas, Patricia E. Edem, Lauren Fougner, Ivan S. Klyuzhin, M. Peter Petric, François Bénard, Arman Rahmim & Carlos Uribe. Quantitative evaluation of PSMA PET imaging using a realistic anthropomorphic phantom and shell-less radioactive epoxy lesions. EJNMMI Phys 9(2) (2022). https://doi.org/10.1186/s40658-021-00429-9.
  • Ronan L. McDermott, Emma M. Dunne, Yizhou Zhao, Alanah M. Bergman, Mitchell C.C. Liu, Devin Schellenberg, Roy M.K. Ma. Stereotactic ablative radiation therapy for colorectal liver metastases. Clinical Colorectal Cancer. In Press. https://doi.org/10.1016/j.clcc.2022.10.006.
  • Claudia Mendez and Ermias Gete. Volume staging for arteriovenous malformation SRS treatment using VMAT. JACMP. 23(12):e13815 (2022). https://doi.org/10.1002/acm2.13815.
  • S. Baker, MD, B. Mou, W. Jiang, M. Liu, MD, Alanah M. Bergman, D. Schellenberg, A.S. Alexander, H. Carolan, S. Atrchian, T. Berrang, A. Bang, N. Chng, Q. Matthews, S. Tyldesley, R.A. Olson. Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 Trial. 114(5):849-55 (2022). https://doi.org/10.1016/j.ijrobp.2022.08.026.
  • Robert Olson, Will Jiang, Mitchell Liu, Alanah M. Bergman, Devin Schellenberg, Benjamin Mou, Abraham Alexander,  Hannah Carolan, Fred Hsu, Stacy Miller, Siavash Atrchian, Elisa Chan, Clement Ho, Islam Mohamed, Angela Lin, Tanya Berrang, Andrew Bang, Nick Chng, Quinn Matthews, Sarah Baker, Vicky Huang, Ante Mestrovic, Derek Hyde, Chad Lund, Howard Pai, Boris Valev, Shilo Lefresene, Scott Tyldesley. Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial. JAMA. 8(11):1644-50. doi:10.1001/jamaoncol.2022.4394.
  • Sarah Baker, Benjamin Mou, Will Jiang, Mitchell Liu,  Alanah M. Bergman, Devin Schellenberg, Abraham S. Alexander, Hannah Carolan, Siavash Atrichian, Tanya Berrang, Andrew Bang, Nick Chng, Wuinn Matthews, Scott Tyldesley and Robert A. Olson. Predictors of early polymetastatic relapse after SABR for up to 5 oligometastases: A secondary analysis of the phase II SABR-5 trial. IJROBP. 114(5):856-61 (2022). https://doi.org/10.1016/j.ijrobp.2022.06.094.
  • Cheryl Duzenli, Elisa K. Chan, Theodora Koulis, Sheri Grahame, Joel Singer, David Morris, Josslynn Spence, Terry Lee, Levi Burns and Robert A. Olsen. Validation of a patient-reported outcome measure for moist desquamation among breast radiotherapy patients. Current Oncology. 29(7):4734-47 (2022). https://doi.org/10.3390/curroncol29070376.
  • Justin Oh, W. James Morris, Ingrid Spadinger, Scott Tyldesley, Mira Keyes, Ross Halperin, Juanita Crook, Vincent Lapointe, Tom Pickles. After ASCENDE-RT: Biochemical and survival outcomes following combined external beam radiotherapy and low-dose-rate brachytherapy for high-risk and unfavourable intermediate-risk prostate cancer, a population-based analysis. Brachytherapy. 21:605-16. https://doi.org/10.1016/j.brachy.2022.05.002.
  • Cheryl Duzenli, Elisa K. Chan, Alanah M. Bergman, Sheri Grahame, Joel Singer, Levi Burns and Robert A Olson. A novel carbon-fibre adjustable reusable accessory (CARA) for supine breast positioning to reduce toxicity in breast adjuvant radiotherapy: a study protocol for a multicentre phase III randomized controlled trial. BMC Cancer. 22:673 (2022). https://doi.org/10.1186/s12885-022-09759-y.
  • Ryan Urban, Justin Wong, Peter Lim, Susan Zhang, Ingrid Spadinger, Robert Olson, Francois Bachand, Clement Ho, Anna V. Tinker, Lovedeep Gondara, Sarah N Hamilton. Cervical cancer patient reported gastrointestinal outcomes: intensity/volumetric modulated vs. 3D conformal radiation therapy. J Gynecol Oncol. 33(5):e70 (2022). https://doi.org/10.3802/jgo.2022.33.e70.
  • S Baker, W Jiang, Benjamin Mou, C R Lund, Mitchell C.C. Liu, Alanah M. Bergman, Devin D. Schellenberg, A S Alexander, Hannah M. Carolan, Siavash Atrchian, Nicholas T. Chng, Quinn Matthews, G Arbour, A Benny, Scott Tyldesley, Robert A. Olson. Progression-free survival and local control following stereotactic ablative radiotherapy for up to 5 oligometastases: an analysis from the population-based phase II SABR-5 trial. IJROBP. 114(4):617-26 (2022). https://doi.org/10.1016/j.ijrobp.2022.05.033.
  • Abdollahi, H., Chin, E., Clark, H., Hyde, D.E., Thomas, Steven, Wu, J., Uribe, C.F., and Rahmim, A. Radiomics-guided radiation therapy: opportunities and challenges. Phys. Med. Biol. 67:12TR02. (2022). https://doi.org/10.1088/1361-6560/ac6fab.
  • Matthew Van Oirschot, Alanah M. Bergman, Wilko F.A.R. Verbakel, Lucy Ward, Isabelle Gagne, Vicky Huang, Nick Chng, Peter Houston, Kerry Symes, Christopher G. Thomas, Parminder Basran, David Bowes, Stephen Harrow, Robert Olson, Suresh Senan, Andrew Warner, David A. Palma, Stewart Gaede. Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial. IJROBP. 114(5):1016-21 (2022). https://doi.org/10.1016/j.ijrobp.2022.01.002.
  • Emma M. Dunne, Simon S. Lo, Mitchell C. Liu, Alanah Bergman, Robert Kosztyla, Eric L. Chang, Ung-Kyu Chang, Samuel T. Chao, Nicolas Dea, Salman Faruqi, Amol J. Ghia, Kristin J. Redmond, Scott G. Soltys, Arjun Sahgal. Thecal Sac Contouring as a Surrogate for the Cauda Equina and Intracanal Spinal Nerve Roots for Spine Stereotactic Body Radiation Therapy (SBRT): Contour Variability and Recommendations for Safe Practice. IJROBP. 112(1):114-120 (2022). https://doi.org/10.1016/j.ijrobp.2021.08.023.

2021 Publications

  • Su, S., Atwal, P., Lobo, J., Duzenli, Cheryl, and Popescu, I.A. A new DOSXYZnrc method for Monte Carlo simulations of 4D dose distributions. Phys. Med. Biol. 66 (2021). https://doi.org/10.1088/1361-6560/ac3a24.
  • Aleef T, Spadinger I, Peacock M, Salcudean SE, Mahdavi SS. Rapid Treatment Planning for Low-dose-rate Prostate Brachytherapy with TP-GAN. In: de Bruijne M. et al. (eds) Medical Image Computing and Computer Assisted Intervention – MICCAI 2021. MICCAI 2021. Lecture Notes in Computer Science, vol 12904: 518-590 Springer, Cham. https://doi.org/10.1007/978-3-030-87202-1_56
  • Aleef, T.A., Spadinger, Ingrid T., Peacock, M.D. et al. Centre-specific autonomous treatment plans for prostate brachytherapy using cGANs. Int J CARS 16, 1161–1170 (2021). doi: 10.1007/s11548-021-02405-1.
  • Carpentier, Emilie E., McDermott, R.L., Dunne, E.M., Camborde, Marie-Laure A., Bergman, Alanah M., Karan, Tania, Liu, M.C.C., Ma, R.M.K. and Mestrovic, Ante. (2021), Four-dimensional dose calculations for dynamic tumour tracking with a gimbal-mounted linear accelerator. J Appl Clin Med Phys, 22: 16-25. https://doi.org/10.1002/acm2.13265.
  • Duzenli C, Koulis T, Menna T, Carpentier E, Arora T, Coope R, Gill B, Lim P, Aquino-Parsons C, Nichol A, Singer J, Ingledew, PA, Grahame S, Chan EK. Reduction in Doses to Organs at Risk and Normal Tissue During Breast Radiation Therapy With a Carbon-Fiber Adjustable Reusable Accessory. Practical Radiation Oncology. 2021 (In Press). doi: 10.1016/j.prro.2021.06.012.
  • Kadoya, N., Sakulsingharoj, S., Kron, T., Yao, A., Hardcastle, N., Bergman, A., Okamoto, H., Mukumoto, N., Nakajima, Y., Jingu, K. and Nakamura, M. (2021), Development of a physical geometric phantom for deformable image registration credentialing of radiotherapy centers for a clinical trial. J Appl Clin Med Phys, 22: 255-265. https://doi.org/10.1002/acm2.13319.
  • Mou B, Hyde D, Araujo C, Bartha L, Bergman A, Liu M. (June 11, 2021) Implementation of Single-Fraction Lung Stereotactic Ablative Radiotherapy in a Multicenter Provincial Cancer Program During the COVID-19 Pandemic. Cureus 13(6): e15598. doi:10.7759/cureus.15598.
  • Sample, C.M., Wu, J., Thomas, S. and Clark, H. (2021), Incorporating parotid gland inhomogeneity into head-and-neck treatment optimization through the use of artificial base plans. J Appl Clin Med Phys, 22: 141-149. https://doi.org/10.1002/acm2.13192.
  • Szpala, S., Huang, V., Zhao, Y., Kyle, A., Minchinton, A., Karan, T. and Kohli, K. (2021), Dosimetry with a clinical linac adapted to FLASH electron beams. J Appl Clin Med Phys, 22: 50-59. https://doi.org/10.1002/acm2.13270.
  • D. Ta, A. Chan, and S. Thomas. Development of a Cardiac and Respiratory Phantom (CARP) for use in Radiosurgery Dosimetry. CMBES Proc., vol. 44, May 2021.

2020 Publications

  • Golshan M, Karimi D, Mahdavi S, Lobo J, Peacock M, Salcudean SE, Spadinger I. Automatic detection of brachytherapy seeds in 3D ultrasound images using a convolutional neural network. Phys Med Biol. 2020, 65(3):035016. doi:10.1088/1361-6560/ab64b5
  • Zhao Y, Khawandanh E, Thomas S, Zhang S, Dunne EM, Liu M, Schellenberg D. Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors. Radiat Oncol. 2020. 15(50). doi: 10.1186/s13014-020-01491-w.
  • Muacevic A, Adler J, Mak D, Fraser I, Ferris R, James K, Liu M, Thomas S, McKenzie M, Lefresne S. Comparison of Rapid to Standard Volumetric Modulated Arc Therapy for Palliative Radiotherapy in Lung Cancer Patients. Cureus. 2020 Oct 6;12(8). doi: 10.7759/cureus.10055.
  • Marban-Orejas MM, Crook JM, Keyes M, Dubash RS, Batchelar D. High-dose-rate brachytherapy for localized penile cancer: Evolution of a technique. Brachytherapy 2019.12.003. GU-PENIS, Vol 19, Issue 2, P201-09, March 1, 2020. doi: 10.1016/j.brachy.2019.12.003.
  • Poon J, Kohli K, Deyell MW, Schellenberg D, Reinsberg S, Teke T, and Thomas S. Technical Note: Cardiac synchronized volumetric modulated arc therapy for stereotactic arrhythmia radioablation — Proof of principle. Medical Physics. 2020;47(8):3567-3572. doi:10.1002/mp.14237.
  • Rostamzadeh M, Ishihara Y, Nakamura M, Popescu IA, Mestrovic A, Gete E, Fedrigo R, Bergman AM. Monte Carlo simulation of 6-MV dynamic wave VMAT deliveries by Vero4DRT linear accelerator using EGSnrc moving sources. J Appl Clin Med Phys. 2020;21(12):206-218. doi:10.1002/acm2.13090.
  • Golshan M, Mahdavi S, Samei G, Lobo J, Pickles T, Morris WJ, Keyes M, Peacock M, Salcudean SE, Spadinger I. Prostate brachytherapy intraoperative dosimetry using a combination of radiographic seed localization with a C-arm and deformed ultrasound prostate contours. Brachytherapy 2020, 19(5): 589-598. doi:10.1016/j.brachy.2020.06.003.
  • Marshall H, Kenworthy JC, Horn FC, Thomas S, Swift AJ, Siddiqui S, Brightling CE, Wild JM. Peripheral and proximal lung ventilation in asthma; short-term variation and response to bronchodilator. Journal of Allergy and Clinical Immunology. 2020 Dec 10. doi: 10.1016/j.jaci.2020.11.035.

2019 Publications

  • Karimi D, Zeng Q, Mathur P, Avinash A, Mahdavi S, Spadinger I, Abolmaesumi P, Salcudean S. Accurate and Robust Segmentation of the Clinical Target Volume for Prostate Brachytherapy. Medical Image Analysis 2019, 57:186-196. doi: 10.1016/j.media.2019.07.005
  • R.Yeung, L.Beaton, T.Rackley, B.Weber, J.Hamm, R.Lee, Marie-Laure A. Camborde, Moira Pearson, Cheryl Duzenli, S.K.Loewen, M.Liu, R.Ma, D.Schellenberg. Stereotactic Body Radiotherapy for Small Unresectable Hepatocellular Carcinomas. Clin. Oncol. 31(6):365-73 (2019). https://doi.org/10.1016/j.clon.2019.01.012
  • Baker L, Olson R, Braich T, Koulis T, Ye A, Ahmed N, Tran E, Lawyer K, Otto K, Smith S, Mestrovic A, Matthews Q. Real-time interactive planning for radiotherapy of head and neck cancer with volumetric modulated arc therapy. Physics and Imaging in Radiation Oncology. 2019. 9:83-88. doi: 10.1016/j.phro.2019.03.002.
  • Kosztyla R, Raman S, Moiseenko V, Reinsberg SA, Toyota B, Nichol A. Dose-painted volumetric modulated arc therapy of high-grade glioma using 3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine positron emission tomography. Br J Radiol. 2019;92(1099):20180901. doi: 10.1259/bjr.20180901.
  • Dunne EM, Sahgal A, Lo SS, Bergman A, Kosztyla R, Dea N, Chang EL, Chang UK, Chao ST, Faruqi S, Ghia AJ, Redmond KJ, Soltys SG, Liu MC. International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT). Radiother Oncol. 2020;145:21-29. doi: 10.1016/j.radonc.2019.11.026.
  • Clark H, Cao F, Leong C, Berthelet E. A practical radiotherapy treatment planning technique for second-incidence cancers that incorporates complete organ-at-risk dose history. J Med Imaging Radiat Sci. 2019 Mar;50(1):74-81. doi: 10.1016/j.jmir.2018.10.008.
  • Beaton L, Bergman A, Nichol A, Aparicio M, Wong G, Gondara L, Speers C, Weir L, Davis M, Tyldesley S. Cardiac death after breast radiotherapy and the QUANTEC cardiac guidelines. Clinical and Translational Radiation Oncology, 19(Nov), p39-45, 2019. doi: 10.1016/j.ctro.2019.08.001.

2018 Publications

  • Mendez C, Colpo N, Duzenli C, Atwal P, Gill B. Technical Note: Development of a phantom for dosimetric comparison of murine micro-CT protocols with optically stimulated luminescent dosimeters. Med Phys. 2018 Jul 3. doi: 10.1002/mp.13079.
  • Hoehr C, Lindsay C, Beaudry J, Penner C, Strgar V, Lee R, Duzenli C. Characterization of the exradin W1 plastic scintillation detector for small field applications in proton therapy. Phys Med Biol. 2018 May 4;63(9):095016. doi: 10.1088/1361-6560/aabd2d.
  • Savard N, Potkins D, Beaudry J, Jirasek A, Duzenli C, Hoehr C. Characteristics of a Ce-Doped silica fiber irradiated by 74 MeV protons. Radiat Med. 2018. 114:19-24. doi:10.1016/j.radmeas.2018.03.010.
  • C. Penner, C. Hoehr, S.Okeeffe, P. Woulfe and C. Duzenli, “Characterization of a Terbium Activated Gadolinium Oxysulfide Plastic Optical Fibre Sensor in Photons and Protons,” 2018 IEEE SENSORS, 2018, pp. 1-1, doi: 10.1109/ICSENS.2018.8589672.
  • Moustakis C, Chan MKH, Kim J, Nilsson J, Bergman A, Bichay TJ, Palazon Cano I, Cilla S, Deodato F, Doro R, Dunst J, Eich HT, Fau P, Fong M, Haverkamp U, Heinze S, Hildebrandt G, Imhoff D, de Klerck E, Köhn J, Lambrecht U, Loutfi-Krauss B, Ebrahimi F, Masi L, Mayville AH, Mestrovic A, Milder M, Morganti AG, Rades D, Ramm U, Rödel C, Siebert FA, den Toom W, Wang L, Wurster S, Schweikard A, Soltys SG, Ryu S, Blanck O. Treatment planning for spinal radiosurgery : A competitive multiplatform benchmark challenge. Strahlenther Onkol. 2018 Sep;194(9):843-854. English. doi: 10.1007/s00066-018-1314-2.
  • Burns L., Teke T., Popescu I., Duzenli C. (2019) Monte Carlo Dosimetry of Organ Doses from a Sweeping-Beam Total Body Irradiation Technique: Feasibility and First Results. In: Lhotska L., Sukupova L., Lacković I., Ibbott G. (eds) World Congress on Medical Physics and Biomedical Engineering 2018. IFMBE Proceedings, vol 68/3. Springer, Singapore. https://doi.org/10.1007/978-981-10-9023-3_76.
  • Burns L., Young S., Beaudry J., Gill B., Coope R., Duzenli C. (2019) Rapid Prototyping, Design and Early Testing of a Novel Device for Supine Positioning of Large Volume or Pendulous Breasts in Radiotherapy. In: Lhotska L., Sukupova L., Lacković I., Ibbott G. (eds) World Congress on Medical Physics and Biomedical Engineering 2018. IFMBE Proceedings, vol 68/3. Springer, Singapore. https://doi.org/10.1007/978-981-10-9023-3_77.
  • Afsari Golshan M, Spadinger I, Samei G, Mahdavi S. (2019) Three-dimensional finite element-based deformation of the prostate boundary in transrectal ultrasound-guided brachytherapy using implanted seeds as control points. In: Lhotska L., Sukupova L., Lacković I., Ibbott G. (eds) World Congress on Medical Physics and Biomedical Engineering 2018. IFMBE Proceedings, vol 68/3.
  • Clark, H., Thomas, S., Reinsberg, S., Moiseenko, V., Hovan, A., & Wu, J. (2018). Heterogeneous radiotherapy dose-outcomes response in parotid glands. Convergent Science Physical Oncology, 4(3), 035001-035001. http://dx.doi.org/10.1088/2057-1739/aac8ea Retrieved from https://escholarship.org/uc/item/33n348ck.
  • Ben Bouchta Y, Goddard K, Petric MP, Bergman AM. Effects of 10 MV and Flattening-Filter-Free Beams on Peripheral Dose in a Cohort of Pediatric Patients. Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1560-1568. doi: 10.1016/j.ijrobp.2018.07.2002.
  • McVicar N, Thomas S, Liu M, Carolan H, Bergman A. Re-irradiation volumetric modulated arc therapy optimization based on cumulative biologically effective dose objectives. J Appl Clin Med Phys. 2018;19(6):341-345. doi:10.1002/acm2.12481

2017 Publications

  • Amir-Khalili A, Hamarneh G, Zakariaee R, Spadinger I, Abugharbieh R. Propagation of registration uncertainty during multi-fraction cervical cancer brachytherapy. Phys Med Biol 2017 Oct 4. 62:8116. doi:10.1088/1361-6560/aa8b37.
  • Zakariaee R, Hamarneh G, Brown CJ, Gaudet M, Aquino-Parsons C, Spadinger I. Association of bladder dose with late urinary side effects in cervical cancer high-dose-rate brachytherapy. Brachytherapy. 2017 Nov-Dec;16(6):1175-1183. doi: 10.1016/j.brachy.2017.07.001.
  • Abu Anas E, Nouranian S, Mahdavi SS, Spadinger I, Morris WJ, Salcudean S, Mousavi P, Abolmaesumi P. Clinical Target-volume Delineation in Prostate Brachytherapy using Residual Neural Networks. MICCAI 2017, Lecture Notes in Computer Science 10433, 365-373.
  • Soliman AS, Burns L, Owrangi A, Lee Y, Song WY, Stanisz G, Chugh BP. A Realistic Phantom for Validating MRI‐based Synthetic CT Images of the Human Skull. Medical Physics. (Accepted)
  • Moqadam, S.M., Grewal, P., Ramani, P., Liu, J., Thomas, S. Use of Electrical Impedance Spectroscopy in vivo to Distinguish Active and Rest Stages of Salivary Glands. J. Med. Biol. Eng. 37, 769–779 (2017). https://doi.org/10.1007/s40846-017-0269-6.
  • Mahdavi SS, Spadinger I, Salcudean S, Kozlowski P, Chang S, Ng T, Lobo J, Nir G, Moradi H, Peacock M, Morris WJ. Focal application of low-dose-rate brachytherapy for prostate cancer: a pilot study. J Contemp Brachytherapy 2017, 9, 3.
  • Wilson B, Otto K, Gete E. (2017), A simple and robust trajectory-based stereotactic radiosurgery treatment. Med. Phys., 44: 240–248. doi:10.1002/mp.12036
  • Gillespie EF, Panjwani N, Golden DW, Gunther J, Chapman TR, Brower JV, Kosztyla R, Larson G, Neppala P, Moiseenko V, Bykowski J, Sanghvi P, Murphy JD. Multi-institutional randomized trial testing the utility of an interactive 3-dimensional contouring atlas among radiation oncology residents. Int J Radiat Oncol Biol Phys. 2017;98(3):547–54. https://doi.org/10.1016/j.ijrobp.2016.11.050
  • Thor M, Owosho AA, Clark HD, Oh JH, Riaz N, Hovan A, Tsai J, Thomas SD, Yom SH, Wu JS, Huryn JM. Internal and external generalizability of temporal dose–response relationships for xerostomia following IMRT for head and neck cancer. Radiotherapy and Oncology. 2017 Feb 28;122(2):200-6.
  • Lo A, Ayre G, Ma R, Hsu F, Akagami R, McKenzie M, Valev B, Gete E, Vallieres I, Nichol A. Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities. Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):443-451. doi: 10.1016/j.ijrobp.2017.09.024.

2016 Publications

  • Zakariaee R, Hamarneh G, Brown C, Gaudet M, Aquino-Parsons C, Spadinger I. Bladder accumulated dose in image-guided high-dose-rate brachytherapy for locally advanced cervical cancer and its relation to urinary toxicity. Phys Med Biol 2016, 61(24): 8408-8424.
    Mahdavi SS, Spadinger IT, Chng NT, Morris WJ. Robustness to source displacement in dual air kerma strength planning for focal low-dose-rate brachytherapy of prostate cancer. Brachytherapy 2016 15(5):642-649.
  • Golshan M, Spadinger I, Chng N. Source strength verification and quality assurance of preloaded brachytherapy needles using a CMOS flat panel detector. Med Phys (2016), 43: 3008-3018.
  • Nouranian S, Ramezani M, Spadinger I, Morris W, Salcudean S, Abolmaesumi P. Learning-based Multi-label Segmentation of Transrectal Ultrasound Images for Prostate Brachytherapy. IEEE Trans Med Imaging. 2016, 35(3): 921- 932.
  • Zakariaee R, Hamarneh G, Brown CJ, Spadinger I. Validation of non-rigid point-set registration methods using a porcine bladder pelvic phantom. Phys Med Biol 2016, 61(2): 825-854.
  • Dosani M, Makarenko S, Akagami R, Ma R, Lo AC, Ailon T, Ayre G, McKenzie M, Hsu F, Gete EA, Nichol A. Long-Term Outcomes for Vestibular Schwannomas: A population-Based Analysis of Patients Treated With Radiation or Surgery in a Multidisciplinary Setting. International journal of radiation oncology, biology, physics. 2016 Oct 1;96(2S):E108.
  • Fortin D, Mestrovic A, Alexander A. Stereotactic ablative radiation therapy with volumetric modulated arc therapy in flattening filter-free mode for low-, intermediate-, and high-risk prostate cancer patients: Are 2 arcs better than 1? Pract Radiat Oncol. 2015 Sep-Oct;5(5):e489-97. doi: 0.1016/j.prro.2015.04.002. PMID: 26055612
  • Marathe K, McVicar N, Li A, Bellyou M, Meakin S, Bartha R. Topiramate induces acute intracellular acidification in glioblastoma. Journal of Neuro-Oncology. 2016 Sep 9:1-8.
  • Wilson B, Gete E. Sci‐Thur AM: YIS–09: Treatment Time Optimization for Trajectory‐Based Deliveries. Medical Physics. 2016 Aug 1;43(8):4930-.
  • Canlas R, McVicar N, Nakano S, Sahota H, Mahajan P, Tyldesley S. Assessment of Adaptive Margins Using a Single Planning Computed Tomography Scan for Bladder Radiotherapy. Journal of Medical Imaging and Radiation Sciences. 2016 Jun 20.
  • Wilson B, Gete E. TH‐EF‐BRB‐10: Dosimetric Validation of a Trajectory Based Cranial SRS Treatment Technique On a Varian TrueBeam Linac. Medical Physics. 2016 Jun 1;43(6):3896-.
  • McVicar N, Popescu IA, Heath E. Techniques for adaptive prostate radiotherapy. Phys Med. 2016 Mar;32(3):492-8. doi: 10.1016/j.ejmp.2016.03.010. Epub 2016 Apr 7. Review. PMID: 27067717.
  • Makarenko S, Akagami R, Ma R, Dosani M, Lo A, Ailon T, Ayre G, McKenzie M, Hsu F, Gete E, Nichol A. Long Term Outcome of Vestibular Schwannoma Treatment in British Columbia. Journal of Neurological Surgery Part B: Skull Base. 2016 Feb;77(S 01):A048.

2015 Publications

  • Corns R, Thomas SD, Huang V. “Pion effects in flattening-filter-free radiation beams” JACMP
  • Lindsay C, Kumlin J, Jirasek A, Lee R, Martinez DM, Schaffer P, Hoehr C. “3D Printed Plastics For Beam Modulation in Proton Therapy” Phys. Med. Biol., Vol. 60, No. 11, N231-40, Jun 2015.
  • Viel F, Lee R, Gete E, Duzenli C. “Amplitude gating for a coached breathing approach in respiratory gated 10 MV flattening filter-free VMAT delivery” J Appl Clin Med Phys. 2015 Jul 8;16(4):5350
  • Clark H, Moiseenko V, Thomas SD, Rackley T, Wu J, Reinsberg S. ”Development of a method for functional aspect identification in parotid using dynamic contrast-enhanced magnetic resonance imaging and concurrent stimulation” Acta Oncol. 2015 Aug 7:1-5
  • Clark H, Hovan A, Moiseenko V, Thomas SD, Wu J, Reinsberg S. “Regional radiation dose susceptibility within the parotid gland: Effects on salivary loss and recovery.” Medical physics 42, no. 4 (2015): 2064-2071.
  • Nouranian S, Ramezani M, Spadinger I, Morris WJ, Salcudean S, Abolmaesumi P. Automatic Prostate Brachytherapy Preplanning Using Joint Sparse Analysis. Automatic Prostate Brachytherapy Preplanning Using Joint Sparse Analysis. MICCAI 2015, Lecture Notes in Computer Science 9350: 415-423
  • Keyes M, Pickles T, Crook J, McKenzie M, Cheung A, Spadinger I, LaPointe V, Bachand WF, Morris J. Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy. Brachytherapy, 2015 14(3):334-341.
  • Spadinger I, Chu J, Afsari Golshan M, Keyes M, Pickles T, Hamm J, Morris WJ. Regional dose metrics as predictors of biochemical failure and local recurrence after low-dose-rate prostate brachytherapy. Brachytherapy, 2015 14(3):350-358.
  • Nouranian S, Mahdavi S, Spadinger I, Morris WJ, Salcudean S, Abolmaesumi P. A Multi-atlas-based Segmentation Framework for Prostate Brachytherapy. IEEE Transactions on Medical Imaging 2015; 34(4):950-961.
  • Nichol A, Ma R, Hsu F, Gondara L, Carolan H, Olson R, Schellenberg D, Germain F, Cheung A, Peacock M, Bergman A, Vollans E, Vellani R, McKenzie M. Volumetric Radiosurgery for 1 to 10 Brain Metastases: A Multicenter, Single-arm, Phase 2 Study. Int J Radiat Oncol Biol Phys. 2015 Oct 22. pii: S0360-3016(15)26582-0. doi: 10.1016/j.ijrobp.2015.10.017.
  • Popescu IA, Atwal P, Lobo J, Lucido J, McCurdy BM. Patient-specific QA using 4D Monte Carlo phase space predictions and EPID dosimetry. InJournal of Physics: Conference Series 2015 (Vol. 573, No. 1, p. 012004). IOP Publishing.
  • Teke T, Duzenli C, Bergman A, Viel F, Atwal P, Gete E. Monte Carlo validation of the TrueBeam 10XFFF phase–space files for applications in lung SABR. Medical physics. 2015 Dec 1;42(12):6863-74.
  • Gete E, Wilson B, Lee R. SU‐E‐T‐53: A New Method for Characterizing the Stability of the Treatment Couch Isocentre. Medical physics. 2015 Jun 1;42(6):3343-.
  • Loewen SK, Vollans E, Crumley C, Sahota H, Kosztyla R, Liu M, Schellenberg D, Camborde ML, Duzenli C, Moiseenko V, Khan M. Liver dosimetric evaluation in biologically based stereotactic body radiotherapy for large inoperable hepatocellular carcinoma. Journal of Radiation Oncology. 2015 Jun 1;4(2):177-84.

2015 Abstracts

  • McVicar N, Atwal P, Lobo J, Popescu IA. Adaptive patient dose assessment using daily 3D cone beam CTs and Monte Carlo simulations. COMP Winter School, Feb 2 – 5, 2015. Delta Grand Oakanagan Resort & Conference Centre, Kelowna, BC, Canada.
  • McVicar N, Atwal P, Lobo J, Popescu IA. Adaptive patient dose assessment using daily 3D cone beam CTs and Monte Carlo simulations. IUPESM World Congress on Medical Physics & Biomedical Engineering, Jun 7 – 12, 2015. Metro Toronto Convention Centre, Toronto, ON, Canada.
  • Su S, Atwal P, Lobo J, Popescu IA. Efficient, all-in-one, Monte Carlo simulations of transit EPID cine-mode dose distributions for patient-specific VMAT quality assurance. IUPESM World Congress on Medical Physics & Biomedical Engineering, Jun 7 – 12, 2015. Metro Toronto Convention Centre, Toronto, ON, Canada.
  • Wilson B, Otto K, Duzenli C, Gete E. A Novel Couch-Gantry Trajectory Based Stereotactic Treatment Method. IUPESM World Congress on Medical Physics & Biomedical Engineering, Jun 7 – 12, 2015. Metro Toronto Convention Centre, Toronto, ON, Canada.
  • Zakariaee R, Hamarneh G, Brown CJ, Spadinger I. Phantom Validation of a Point-Set Deformable Registration Method using Pig Bladder. IUPESM World Congress on Medical Physics & Biomedical Engineering, Jun 7 – 12, 2015. Metro Toronto Convention Centre, Toronto, ON, Canada.
  • Giambattista J, McVicar N, Maas B, Ho C, Martin M, Berthelet E. Magnitude and timing of GTV response to neoadjuvant chemotherapy and concurrent chemo-radiation in the treatment of locally advanced nasopharyngeal carcinoma. Canadian Association of Radiation Oncology (CARO) Annual Scientific Meeting, September 9-12, 2015. Delta Grand Okanagan Resort & Conference Centre, Kelowna, BC, Canada. Oral Presentation
  • Nica L, McVicar N, Popescu T, Zakariaee R, Pearson M, Arora T, Soo J, Giddings A, Berthelet E. A methodology to assess dosimetric changes in the target volumes and organs at risk during radiotherapy for head and neck cancer patients using weekly kV CBCT and deformable registration. Canadian Association of Radiation Oncology (CARO) Annual Scientific Meeting, September 9-12, 2015. Delta Grand Okanagan Resort & Conference Centre, Kelowna, BC, Canada. Poster Presentation
  • E. Kahwandahn, C Duzenli, H Clark, J Wu, S Thomas and E Berthelet, Performance Optimization of Atlas-Based Autosegmentation of Parotid Glands for Headand Neck Radiotherapy Planning unsing an in-house Atlas Library, CARO Kelowna, July, Radiotherapy and Oncology (116) S32

2015 Publications

  1. Keyes M, Miller S, Pickles T, Halperin R, Kwan W, Lapointe V, McKenzie M, Spadinger I, Pai H, Chan EK, Morris WJ. Late Urinary Side Effects 10 Years After Low-Dose-Rate Prostate Brachytherapy: Population-Based Results From a Multiphysician Practice Treating With a Standardized Protocol and Uniform Dosimetric Goals.  Int J Radiat Oncol Biol Phys 2014; (in press).
  2. Nouranian S, Mahdavi S, Spadinger I, Morris WJ, Salcudean S, Abolmaesumi P.  A Multi-atlas-based Segmentation Framework for Prostate Brachytherapy.  IEEE Transactions on Medical Imaging 2014; (in press).
  3. Murphy JD, Hattangadi-Gluth J, Song WY, Vollans E, Camborde ML, Kosztyla R, Loewen SK, Crumley C, Moiseenko V.  Liver toxicity prediction with stereotactic body radiation therapy: The impact of accounting for fraction size.  Pract Radiat Oncol. 2014;4(6):372-7.
  4. Deman P, Atwal P, Duzenli C, Thakur Y, Ford N.  Dose measurements for dental cone-beam CT: A comparison with MSCT and panoramic imaging.  Phys Med Biol. 2014 Jun 21;59(12):3201-22.
  5. Bergman AM, Gete E, Duzenli C, Teke T.  Monte Carlo modeling of HD120 multileaf collimator on Varian TrueBeam linear accelerator for verification of 6X and 6X FFF VMAT SABR treatment plans. JACMP, 2014, 15(3).
  6. Gaudet M, Lim P, Yuen C, Zhang S, Spadinger I, Dubash R, Aquino-Parsons C.  Comparative analysis of rectal dose parameters in image-guided high-dose-rate brachytherapy for cervical cancer with and without a rectal retractor. Brachytherapy, 2014(3):257-262.
  7. Morris WJ, Pickles T, Keyes M, McKenzie M, Spadinger I. Pride or prejudice: Does Phoenix flatter radiation therapy? Brachytherapy 2014, 13(3):299-303.
  8. Spadinger I, Morris WJ. Rebuttal to Drs Stone and Stock. Brachytherapy 2014 (1):32-41.
  9. Morris WJ, Spadinger I, Keyes M, Hamm J, McKenzie M, Pickles T. Whole prostate D90 and V100: A dose-response analysis of 2000 consecutive (125)I monotherapy patients. Brachytherapy 2014 (1):32-41.
  10. Chan EK, Keyes M, Pickles T,  Lapointe V, Spadinger I, McKenzie M, Morris WJ.  Decline in acute urinary toxicity: A long-term study in 2011 patients with prostate brachytherapy within a provincial institution . Brachytherapy 2014, 13(1):46–52. 
  11. Lo AC, Morris WJ, Lapointe V, Hamm J, Keyes M, Pickles T, McKenzie M, Spadinger I. Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival. Int J Radiat Oncol Biol Phys 2014;88(1):87-93.
  12. Sonier  M, Gete E,  Herbert C, McKenzie M ,  Murphy J,  and Moiseenko V. Intensity-modulated stereotactic radiosurgery for arteriovenous malformations: guidance for treatment planning. Radiation Oncology 2014, 9:73
  13. Kohli K, Liu J. Schellenberg D, Karvat A, Parameswaran A, Grewal P, Thomas S. Prototype development of an electrical impedance based simultaneous respiratory and cardiac monitoring system for gated radiotherapy. Biomed Eng Online. 2014 Oct 14;13:144. doi: 10.1186/1475-925X-13-144.
  14. Clark H, Wu J, Moiseenko V, Lee R, Gill B, Duzenli C, Thomas S. “Semi-automated contour recognition using DICOMautomaton.” In Journal of Physics: Conference Series, vol. 489, no. 1, p. 012088. IOP Publishing, 2014.
  15. Clark H, Thomas S, Moiseenko V, Lee R, Gill B, Duzenli C, Wu J. “Automated segmentation and dose-volume analysis with DICOMautomaton.” In Journal of Physics: Conference Series, vol. 489, no. 1, p. 012009. IOP Publishing, 2014.

2015 Book Chapters                                                                         

  1. S.D. Thomas, A. Bergman, D. Schellenberg “Planning Considerations in Stereotactic Ablative Body Radiotherapy” The CAMRT Dosimetry 3 Course Book.

2015 Abstracts

  1. Zakariaee R, Gaudet M, Dubash R, Parsons C, Brown CJ, Spadinger I.  A Method to Estimate the Spatial Distribution of Bladder Hot Spots in Image-Guided Intracavitary Brachytherapy of Cervical Cancer. Brachytherapy 2014, 13(Supplement 1): S88. ABS, 2014 Annual Meeting, April 3 – April 5, 2014. Manchester Grand Hyatt, San Diego, California.
  2. Afsari Golshan. M, Spadinger I, Morris JW, Hamm J, Keyes M. Regional Dosimetric Analysis of LDR Prostate Brachytherapy Patients with Confirmed Local Failure: A Case-Control Study. Brachytherapy 2014, 13(Supplement 1): S38. ABS, 2014 Annual Meeting, April 3 – April 5, 2014. Manchester Grand Hyatt, San Diego, California.
  3. Bachand F, Aquino-Parsons, C, Lim P, Dubash R, Yuen C.  Uterine Perforation in HDR Intrauterine Brachytherapy: Training is recommended.
  4. Karan T, Viel F, Atwal P, Gete E, Camborde M, Horwood R, Strgar V, Duzenli C, Characterization of the Dose Per Pulse Dependence of Various Detectors Used in Quality Assurance of FFF Treatment Plans, Accepted for oral presentation at the AAPM 56th Annual Meeting, Austin, US, July 20-24, 2014
  5. Viel F, Duzenli C, Camborde M, Strgar V, Horwood R, Atwal P, Gete E, Karan T, Flattening Filter Free VMAT Quality Assurance: Dose Rate Considerations for Detector Response, Accepted for poster presentation at the COMP 60th Annual Scientific Meeting, Banff, Canada, July 9-12, 2014
  6. Zakariaee R, Brown CJ, Hamarneh G, Parsons CA, Spadinger I.  Estimation of Bladder-Wall Cumulative Dose in Multi-Fraction Image-Based Gynaecological BrachyTherapy Using Deformable Point Set Registration.  Accepted to Comp 60th Annual Scientific Meeting, 2014, Banff, Canada July 9 – 12, 2014
  7. Popescu IA, Lobo J, Sawkey D, Svatos M.  TrueBeam Monte Carlo absolute dose calculations using monitor chamber backscatter simulations and linac-logged target current. Accepted as Oral Presentation at the 2014 AAPM Annual Meeting, Austin, TX.
  8. Beaudry J, Cropp R, Bergman A. Implementation of a Clinical Lung Tumour High Dose Containment VerificationProcedure using Respiratory Cone-Beam CT (4DCBCT) on a Varian TrueBeam Linac. Accepted as poster presentation to COMP 60th Annual Scientific Meeting, Banff, Canada, July 9-12, 2014
  9. Spadinger I, Morris WJ, Chu J, Afsari Golshan M, Keyes M.  Regional dose metrics and their relationship to treatment failure in I-125 prostate brachytherapy patients.  Abstract E33-0615, ESTRO 33 (Vienna, April 2014).
  10. Mahdavi S, Morris WJ, Salcudean S, Chang S, Kozlowski P, Spadinger I. Combining Multi-Modality Imaging and Transperineal Mapping Biopsy to Guide the Focal Application of Low-Dose-Rate Brachytherapy for Prostate Cancer: An Ethics Approved Pilot Study.  Brachytherapy 2014, 13(Supplement 1): S122-S123. 35th Annual Meeting of the American Brachytherapy Society (San Diego, April 2014).
  11. Keyes M, Miller S, Chan E, Halperin H, Kwan K, Lapointe V, McKenzie M, Morris WJ, Spadinger I, Pickles T. Late Urinary Side Effects after LDR Prostate Brachytherapy: The British Columbia Cancer Agency Experience.  Brachytherapy 2014, 13(Supplement 1): S39-S40. 35th Annual Meeting of the American Brachytherapy Society (San Diego, April 2014).
  12. Keyes M, Pickles P, Spadinger I, LaPointe V, McKenzie M, Morris WJ.  Aging Effect and Long-Term Erectile Function following I-125 Permanent Prostate Brachytherapy.  Brachytherapy 2014, 13(Supplement 1): S16-S17. 35th Annual Meeting of the American Brachytherapy Society (San D 
  13. Gete E, Duzenli C, Karan T, and Strgar V. A study of dose rate dependence of the Octavius 1000 SRS array for Flattening Free and Flattened photon beams. Poster presentation at ESTRO33, Vienna, Austria, 4-8 April 2014.
  14. Wilson B, Teke T, Duzenli C and Gete, E. Development of Quality Assurance Methods for Trajectory based Cranial SRS Treatments. Accepted for oral presentation at COMP 2014, Banff, July 9 – 12. 2014).
  15. Corns, Thomas SD, Huang V. Clinical Subtleties of Flattening-Filter-Free Beams. Proceedings of the Canadian Organization of Medical Physicists July 2014.
  16. Teke T, Huang V, Millette MP, Thomas SD.  4D VMAT dose calculation methodology to investigate the interplay effect: experimental validation using TrueBeam Developer Mode and Gafchromic film. Proceedings of the Canadian Organization of Medical Physicists July 2014.
  17. Huang V, Teke T, Thomas SD.  Evaluation of VMAT interplay effect for lung SABR using TrueBeam 10Xfff beam ” Proceedings of the Canadian Organization of Medical Physicists July 2014.
  18. Clark H, Wu J, Moiseenko V, Thomas SD.  Distributed, asynchronous, reactive dosimetric and outcomes analysis using DICOMautomaton. Proceedings of the Canadian Organization of Medical Physicists July 2014.
  19. Clark H, Thomas SD, Moiseenko V, Hovan A, Wu J. The influence of regional dose sensitivity on salivary loss and recovery in the parotid gland. Proceedings of the Canadian Organization of Medical Physicists July 2014.
  20. Grewal PK, Thomas SD, Karvat A, Golnaraghi F, Liu J, Kalpagam K, Kohli K.  Electrical Impedance Spectrocopy to Monitor Salivary Function.  Proceedings of the Canadian Medical and Biological Engineering Society May 2014.
  21. Marhsall H, Thomas SD, Parra-Robles J, Siddiqui S, Kay R, Brightling CE, Wild JM.  Multi-Nuclear MR Imaging of Ventilation and Perfusion Distribution Response to Bronchodilator in Asthma. Proceeding of the International Society of Magnetic Imaging in Medicine May 2014.
  22. Marshall H, Thomas SD, Parra-Robles J, Brightling CE, Wild JM.  Imaging VQ Distribution Response to Bronchodilator in Asthma using Hyperpolarized 3He and 1H MRI. Proceeding of the American Thoracic Society May 2014.
  23. Grewal PK, Thomas SD, Karvat A, golnaraghi F, Liu J, Krishnan K, and Kohli K.  Time Dependant Electrical Impedance Spectroscopy of Salivary glands.  Proceedings of Frontiers in Biophysics, March 2014.
  24. Clark H, Thomas SD, Moiseenko V, Lee R, Gill B, Duzenli C, Wu J.  Automatic Segmentation and Dose-Volume Analysis with DICOMautomaton.  J.Physics: Conf.Ser. 489 (2014)
  25. Clark H, Wu J, Moiseenko V, Lee R, Gill B, Duzenli C, Thomas SD.  Semi Automated Contour Recognition using DICOMautomaton.  J.Phys: Conf. 489 (2014)
  26. Viel F, Duzenli C, Camborde M, Strgar V, Horwood R, Atwal P, Gete E, Karan T, Flattening Filter Free VMAT Quality Assurance: Dose Rate Considerations for Detector Response, Accepted for poster presentation at the COMP 60th Annual Scientific Meeting, Banff, Canada, July 9-12, 2014.
  27. Morris J, Spadinger I, Chu J, Afsari Golshan M.  Regional dose metrics may explain conflicting reports regarding the dose-response for low dose rate prostate brachytherapy: an analysis of 2000 consecutive cases.  2014 CARO 28th Annual Scientific Meeting (St John’s, NL, August 2014).
  28. Mahdavi SS, Morris WJ, Salcudean SE, Chang SD, Kozlowski P, Spadinger I.  Focal application of low-dose-rate brachytherapy for prostate cancer: An ethics approved pilot study.  7th International Symposium on Focal Therapy and Imaging in prostate and kidney cancer. (Pasadena, USA, Aug 21-23, 2014)
  29. Schellenberg D, Weber B, Loewen S, Khan M, Duzenli C, Pearson M, Lee R, Vollans E, Camborde ML, Ma R. “The Use of Fluoroscopy on the TrueBeam Linear Accelerator as a Means to Identify Stereotactic Ablative Liver Patients Suitable for Respiratory Gated Treatment.” Poster Presentation, 2015 CARO AGM (St John’s, NFLD).

2013 Publications

  1. Gete E, Duzenli C, Milette MP, Mestrovic A, Hyde D, Bergman MA, Teke T. A Monte Carlo approach to validation of FFF VMAT treatment plans for the truebeam linac. Medical Physics 40(2) January 2013. 021707-1 – 021707-13.</li
  2. Chin E, Loewen S, Nichol A Otto K. 4D VMAT, gated VMAT, and 3D VMAT for stereotactic body radiation therapy in lung. Phys. Med. Biol. 58:749-70 (2013).
  3. McParland N, Pearson M, Wong J, Sigur I, Stenger C, Tyldesley S. Quantifying daily variation in volume and dose to the prostate, rectum and bladder using cone-beam computerised tomography. Journal of Radiotherapy in Practice. 1-8 (Accepted April 2013)

2013 Abstracts

  1. Camborde ML, Vollans E, Crumley C, Ma R, Kosztyla R, Moiseenko V, Duzenli C, Liu M, Schellenberg D, Khan M, Loewan SK. Incorporating Lyman-Kutcher-Burman NTCP modeling with stereotactic body radiotherapy to minimize radiation-induced liver disease for inoperable hepatocellular carcinoma. COMP/CARO 2013. Accepted.
  2. Camborde ML, Vollans E, Crumley C, Ma R, Kosztyla R, Moiseenko V, Duzenli C, Schellenberg D, Khan M, Loewen SK. Mean liver dose evaluation by Lyman NTCP modeling with sterotactic body radiotherapy to minimize radiation-induced liver disease for inoperable hepatocellular carcinoma. Submitted February 2013, ASTRO. Accepted as a poster.
  3. Kosztyla R, Moiseenko V, Reinsberg SA, Ma R, McKenzie M, Wilson D, Benard F, Vertinsky T, Toyota B, Nichol A. Estimating cell density using fractional anisotropy from postoperative diffusion tensor imaging of high-grade glomas. AAPM 2013. Accepted for oral presentation.
  4. Kosztyla R, Moiseenko V, Stefan A, Reinsberg Stefan A, Ma R, McKenzie M, Wilson D, Benard F, Vertinsky T, Toyota B, Nichol A. Utility of postoperative diffusion tensor imaging for the definition of high-grade gloma radiotherapy target volumes. CARO and COMP 2013. Accepted
  5. Tam C, Spadinger I, Chng N, Morris William J, Keyes M, Mahdavi S, Moradi M, Lobo J, Salcudean SE. Using ultrasound to assist in CT contouring for post-operative Dosimetry in prostate brachytherapy. Submitted February 2013. COMP/CARO
  6. Viel F, Gete E, Duzenli C, Lee R. Developing QA procedures for gated VMAT SABR treatments. AAPM 2013. Accepted for oral presentation.
  7. Clark H, Wu J, Moiseenko V, Lee R, Gill B, Duzenli C, Thomas S. Semi-automated contour recognition using DICOMautomaton. Submitted to ICCR, Australia. January 2013.
  8. Clark H, Wu J, Moiseenko V, Lee R, Gill B, Duzenli C, Thomas S. Automated segmentation and Dose-Volume analysis with DICOMautomaton. Submitted to ICCR, Australia. January 2013.
  9. Viel F, Lee R, Gete E, Duzenli C. Considerations for delivering acceptable gated VMAT SABR plans for large liver PTVS. Submitted 28 February 2013. COMP 2013. Accepted for Oral presentation.
  10. Zakariaee R, Spadinger I, Gaudet M, Parsons C. A method to estimate the spatial distribution of bladder hot spots in image-guided intracavitary brachytherapy of cervical cancer. Submitted February 2013. COMP/CARO
  11. Spadinger I, Golshan M, Morris WJ, Hamm J, Keyes M. Case-Control Dosimetric Analysis of low dose rate prostate brachytherapy patients with confirmed local failure. Submitted February 2013. COMP/CARO.
  12. Lo A, Morris WJ, Lapointe V, Hamm J, Pickles T, Keyes M, McKenzie M, Spadinger I. PSA value and trend 45 to 60 months after I125 brachytherapy is highly predictive for long-term freedom from biochemical failure. Submitted February 2013. CARO.
  13. Nouranian S, Mahdavi Sara S, Spadinger I, Morris WJ, Salcudean SE, Abolmaesumi P. Multi-atlas-based automatic 3D-Segmentation for Prostate Brachytherapy in Transrectal Ultrasound Images. Submitted January 2013.
  14. Gaudet M, Lim P, Spadinger I, Yuen C, Zhang S, Wong F, Lester B, Bachand F, Aquino-Parsons C. Bladder volume variation reduces long-term toxicity of image-guided brachytherapy for cervical cancer. COMP/CARO. Accepted January 2013
  15. Gaudet M, Lim P, Yuen C, Zhang S, Spadinger I, Dubash R, Aquino-Parsons C. Comparative analysis of rectal dose parameters in image-guided HDR brachytherapy for cervical cancer with and without a rectal retractor. COMP/CARO 2013.
  16. Tam C, Spadinger I, Chng N, Morris W, Keyes M, Mahdavi S, Moradi Mehdi, Lobo J, Salcudean S. Using ultrasound to assist in CT contouring for post-operative Dosimetry in prostate brachtherapy. Accepted for poster presentation. COMP/CARO 2013
  17. Deman P, Atwal P, Duzenli C, Thakur Y, Ford N. Dose Measurement Methodology for dental cone-beam CT. AAPM 2013. Accepted.

2012 Publications

  1. Olson R, Caon J, Tyldesley S, Bergman A, Fong M, Ma V, Vellani R, Khan M, Goddard K. National survey of healthcare providers views on the risk of inadvertent exposure of pregnant patients to ionizing radiation in Canadian radiotherapy departments. Journal of Radiation Oncology, 1(1): 81-85, 2012.
  2. Caon J, Olson R, Tyldesley S, Bergman A , Bobinski M, Fong M, Ma V, Vellani R, Goddard K. Assessing the risk of inadvertent radiation exposure of pregnant patients during radiation therapy planning and treatment in British Columbia. Practical Radiation Oncology, 2(3):179-185,2012.
  3. Li XA, Alber M, Deasy JO, Jackson A, Ken Jee KW, Marks LB, Martel MK, Mayo C, Moiseenko V, Nahum AE, Niemierko A, Semenenko VA, Yorke ED. The use and QA of biologically related models for treatment planning: Short report of the TG-166 of the therapy physics committee of the AAPM. Medical Physics, 2012, 39, 1386-1409
  4. Moiseenko V, LaPointe V, James K, Yin L, Liu M, Pawlicki T. Biological consequences of MLC calibration errors in IMRT delivery and QA. Medical Physics, 2012, 39, 1917-1924
  5. Simpson DR, Song WY, Moiseenko V, Rose BS, Yashar CM, Mundt AJ, Mell LK. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin. International Journal of Radiation Oncology Biology Physics, 2012, 83, e81-e86
  6. Herbert C, Liu M, Tyldesley S, Morris WJ, Joffres M, Khaira M, Kwan W, Moiseenko V, Pickles T. Biochemical control with radiotherapy improves overall survival in intermediate and high risk prostate cancer patients who have an estimated 10-year overall survival of >90%. International Journal of Radiation Oncology Biology Physics, 2012, 83, 22-27
  7. Herbert C, Moiseenko V, McKenzie M, Redekop G, Hsu F, Gete E, Gill B, Lee R, Luchka K, Haw C, Lee A, Toyota B, Montgomery M. Factors predictive of symptomatic radiation injury following linear accelerator-based stereotactic radiosurgery for intracerebral arteriovenous malformations. International Journal of Radiation Oncology Biology Physics, 2012, 83, 872-877
  8. Bhandare N, Moiseenko V, Song WY, Morris CG, Bhatti MT, Mendenhall WM. Severe dry-eye syndrome after radiotherapy for head-and-neck tumors. International Journal of Radiation Oncology Biology Physics, 2012, 82, 1501-1508
  9. Moiseenko V, Wu J, Hovan A, Saleh Z, Apte A, Deasy JO, Harrow S, Rabuka C, Muggli A, Thompson A. Treatment planning constraints to avoid xerostomia in head and neck radiotherapy:  an independent test of QUANTEC criteria using a prospectively collected dataset. International Journal of Radiation Oncology Biology Physics, 2012, 82, 1108-114
  10. Koszytla R, Carolan H, Balkwill S, Moiseenko V, Kwan W. Evaluation of Dosimetric Consequences of Seroma Contour Variability in Accelerated Partial Breast Irradiation Using a Constructed Representative Seroma Contour. International Journal of Radiation Oncology, biology, Physics. 2012, 84 (2), 527 – 532.
  11. Qiu Y, Moiseenko V, Aquino-Parsons C, Duzenli C. Equivalent doses for gynecological patients undergoing IMRT or RapidArc with kilovoltage cone beam CT. Journal of Radiotherapy and Oncology. 2012, 104, 257-262.
  12. Moris W J, Keyes M, Spadinger I, Kwan W, Liu M, McKenzie M, Pai H, Pickles T, Tyldesley S. Population based, 10 year oncologic outcoms after low dose rate brachytherapy for low-and intermediate-risk prostate cancer. In Press in Cancer.
  13. Lee R, Chan EK, Kosztyla R, Liu M, Moiseenko. Dose-distance metric that predicts late rectal bleeding in patients receiving radical prostate external-beam radiotherapy. Phys. Med. Biol. 57 (2012) 8297″-8307.

2012 Abstracts

  1. S. K. Loewen, V. Moiseenko, I. A. Popescu, R. Vellani, M. Fong, M. Liu,
    “Monte Carlo Calculation of Dose Distribution in Oligometastatic Patients Planned for Spine Stereotactic Ablative Radiotherapy”. Presented at the Annual Meeting of the Canadian Association of Radiation Oncology (CARO) in Ottawa, Canada (September 12-15, 2012).
  2. Y. Graves, G. Kim, M. Folkerts, T. Teke, I. A. Popescu, L. Cervino, Z. Tian, X. Jia, S. Jiang, “A GPU-based Monte Carlo QA tool for IMRT and VMAT”. Presented at the 54th Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Charlotte, NC, USA (July 29 – August 2, 2012).
  3. T. Teke, C. Duzenli, A. Mestrovic, D. Hyde, M. P. Milette, I. A. Popescu, E. Gete, “Monte Carlo simulations for Quality Assurance of Varian TrueBeam 6MV FFF RapidArc SBRT treatments”. Presented at the 54th Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Charlotte, NC, USA (July 29 – August 2, 2012).
  4. E. Heath, I. Badragan, I. A. Popescu, “4D Monte Carlo simulations of beam and patient motion using EGSnrc/BEAMnrc”. Presented at the 54th Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Charlotte, NC, USA (July 29 – August 2, 2012).
  5. G. Asuni, I. A. Popescu, B. McCurdy, “Approach to evaluate the accuracy of individual control-points of a VMAT delivery measured by an EPID”. Presented at the Annual Meeting of the Canadian Organization of Medical Physics (COMP), Halifax, NS, Canada (July 2012).
  6. M. Podesta, I. A. Popescu, L. Persoon, S. Nijsten, F. Verhaegen, “Monte Carlo simulation of dose rate maps for IMRT/VMAT treatments using standard and FFF beams”. Presented at the Third European Workshop on Monte Carlo Treatment Planning, Seville, Spain (May 2012).
  7. Bergman, T. Teke, I. A. Popescu, “Monte Carlo Commissioning of HD120 Multi-Leaf Collimator on Varian TrueBeam Unit for Verification of Clinical Volumetric Modulated Arc Therapy (VMAT) Treatment Plans”. Presented at the Third European Workshop on Monte Carlo Treatment Planning, Seville, Spain (May 2012).
  8. Karan T, Moiseenko V, Gill B, Horwood R, Minchinton A. Applications of 6MV FFF photon beams in optimizing respiratory gated liver SBRT. Presented at the AAPM meeting in charlotte, North Carolina this year (Jul 29 – Aug 2).
  9. Kosztyla R, Chan E, Hsu F, Wilson D, Ma R, Cheung A, Moiseenko V, Zhang S, Benard F, Nichol A. Comparison of High-Grade giloma Relapses with Radiotherapy Target Volumes Obtained from MRI and 18F-FDOPA PET. Accepted for poster presentation in Boston in fall this year.
  10. Kosztyla R, Hsu F, Wilson D, Ma R, Cheung A, Moiseenko V, McKenzie M, Zhang S, Benard F, Nichol A. A radiotherapy planning study of high-grade glioma contouring on magnetic resonance imaging (MRI) and 18F-FDOPA positron emission tomography (PET) with multiple observers [Abstract]. Can J Neurol Sci. 2012; 39(1 Suppl. 1):S14. (Paper presented at: 15th Biennial Canadian Neuro-Oncology Meeting; 2012 Feb 10-11; Vancouver, (BC).
  11. E. Chin, S. Loewen, A. Nichol and K. Otto, “Comparing 4D-VMAT, gated-VMAT and 3D-VMAT in SBRT treatment of lung cancer,” Young Investigator Symposium. COMP 2012 Annual Scientific Meeting, Halifax, Canada (July 2012).
  12. E. Chin, S. Loewen, H. Sahota, A. Nichol, E. Heath, K. Otto, ” 4D-VMAT vs. Gated VMAT in Lung Cancer SBRT,” Poster. AAPM 2012 Annual Scientific Meeting, Charlotte, USA (August 2012).
  13. A Bergman, E Vollans, C Duzenli. Comparison of Treatment Planning and Delivery Performance of VMAT versus IMRT. 2012 Canadian Organisation of Medical Physics, Annual Scientific Meeting, Halifax. July 11-14th.
  14. Sonier M, Moiseenko V, Gete E, Herbert C, McKenzie M, “Patient Stratification based on Improvements in Conformity Indices and Normal Tissue Sparing with IMRT in Arteriovenous Malformation Treatments”. To be presented at the annual AAPM meeting in Charlotte, North Carolina (Jul.29-Aug.2, 2012). It has been accepted into General Poster Discussion Session, Therapy Posters, Poster Number SU-E-T-642.
  15. Hyde D, Teke T, Mestrovic A, Gete E, Schmid M. Lung SBRT: Dosimetric accurancy of the Analytical Anisotropic Algorithm (AAA) for 6MV FFF RapidArc planning. 2012 Canadian Organisation of Medical Physics, Annual Scientific Meeting, Halifax. July 11-14th.
  16. Gete E, Duzenli C, Teke T. Benchmarking of a Varian TrueBeam 6MV FFF photon beam IAEA Compliant Monte Carlo phase space data using BEAMnrc/DosXYZnrc. Presented at World Congress on Medical Physics and Biomdedical Engineering, Beijing, China, May 26-31, 2012.
  17. Loewen Sk, McKenzie M, Gete E, Lee R, Luckha K, Moiseenko V, Herbert C, Toyoto B, Redekop G, Haw C, Lee A, Martin M, Arzoumanian Y. Integration of Diffusion Tensor Tractegraphy in patients with arteriovenous malformation treated with sterotactic radiosurgery. Presented at the 26th CARO Annual Scientific Meeting, September 12 “- 15, 2012, Ottaw, On.
  18. Kosztyla R, Chan E, Hsu F, Wilson D, Ma R, Cheung A, Moiseenko V, Zhang S, Benard F, Nichol A.  Comparison of High-Grade giloma Relapses with Radiotherapy Target Volumes Obtained from MRI and 18F-FDOPA PET. Int J Radiat Oncol Biol Phys 2012;84(3 Suppl.):S270-1.
  19. Chan EK, Kosztyla R, Fred Hsu F, Wilson D, Ma R, Cheung A, Moiseenko V, Zhang S, Benard F, Nichol A. Correlation of high-grade glioma relapse volumes with the radiotherapy target volumes delineated using 18F-FDOPA PET tracer uptake. Radiother Oncol. 2012;104(Supp 2):S70. Presented at the 26th Annual Meeting of the Canadian Association of Radiation Oncology (2012 Sept 12-15); Ottawa, ON).

2011 Publications

  1. Chng N, Spadinger I, Morris WJ, Usmani N, Salcudean S. Prostate brachytherapy postimplant dosimetry: automatic plan reconstruction of stranded implants. Med Phys 2011 Jan;38(1):327-342.
  2. Herbert C, Liu M, Tyldesley S, Morris WJ, Joffres M, Khaira M, Spadinger I, et al. Biochemical Control with Radiotherapy Improves Overall Survival in Intermediate and High-Risk Prostate Cancer Patients Who Have an Estimated 10-Year Overall Survival of >90%. Int J Radiat Oncol Biol Phys 2011 Nov 11.
  3. Herbert C, Moiseenko V, McKenzie M, Redekop G, Hsu F, Gete E, et al. Factors Predictive of Symptomatic Radiation Injury After Linear Accelerator-Based Stereotactic Radiosurgery for Intracerebral Arteriovenous Malformations. Int J Radiat Oncol Biol Phys 2011 Dec 28.
  4. Herbert C, Moiseenko V, McKenzie M, Redekop G, Hsu F, Gete E, Lee R, Luchka K, et al. Factors predictive of obliteration after arteriovenous malformation radiosurgery. Can J Neurol Sci 2011 Nov;38(6):845-850.
  5. Herbert C, Morris WJ, Hamm J, Lapointe V, McKenzie M, Pickles T, Spadinger I, et al. The effect of loose versus stranded seeds on biochemical no evidence of disease in patients with carcinoma of the prostate treated with iodine-125 brachytherapy. Brachytherapy 2011 Nov-Dec;10(6):442-448.
  6. Keyes M, Spadinger I, Liu M, Pickles T, Pai H, Hayden A, Kwan W, et al. Rectal toxicity and rectal dosimetry in low-dose-rate iodine-125 permanent prostate implants: A long-term study in 1006 patients. Brachytherapy 2011 Jul 13.
  7. Mahdavi SS, Chng N, Spadinger I, Morris WJ, Salcudean SE. Semi-automatic segmentation for prostate interventions. Med Image Anal 2011 Apr;15(2):226-237.
  8. Mahdavi SS, Spadinger I, Chng N, Salcudean SE, Morris WJ. Semiautomatic segmentation for prostate brachytherapy: Dosimetric evaluation. Brachytherapy 2011 Sep 23.
  9. Moiseenko V, Song WY, Mell LK, Bhandare N. A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy. Radiat Oncol 2011 Jun 6;6:61.
  10. Qiu Y, Popescu IA, Duzenli C, Moiseenko V. Mega-voltage versus kilo-voltage cone beam CT used in image guided radiation therapy: comparative study of microdosimetric properties. Radiat Prot Dosimetry 2011 Feb;143(2-4):477-480.
  11. Shaffer R, Pickles T, Lee R, Moiseenko V. Deriving prostate alpha-beta ratio using carefully matched groups, long follow-up and the phoenix definition of biochemical failure. Int J Radiat Oncol Biol Phys 2011 Mar 15;79(4):1029-1036.
  12. Shaffer R, Vollans E, Vellani R, Welsh M, Moiseenko V, Goddard K. A radiotherapy planning study of RapidArc, intensity modulated radiotherapy, three-dimensional conformal radiotherapy, and parallel opposed beams in the treatment of pediatric retroperitoneal tumors. Pediatr Blood Cancer 2011 Jan;56(1):16-23.
  13. Spadinger I, Morris WJ, Keyes M, Liu M, Shaffer R, Thompson A, et al. Quadrant dosimetry as a predictor of biochemical relapse in 125I prostate brachytherapy. Brachytherapy 2011 Mar-Apr;10(2):87-97.
  14. Teke T, Gill B, Duzenli C, Popescu IA. A Monte Carlo model of the Varian IGRT couch top for RapidArc QA. Phys Med Biol 2011 Dec 21;56(24):N295-305.
  15. Usmani N, Chng N, Spadinger I, Morris WJ. Lack of significant intraprostatic migration of stranded iodine-125 sources in prostate brachytherapy implants. Brachytherapy 2011 Jul-Aug;10(4):275-285.
  16. Caon J, Olson R, Tyldesley S, Bergman A, et al. Assessing the risk of inadvertent radiation exposure of pregnant patients during radiation therapy planning and treatment in BC. Practical Radiation Oncology. Published online 10 October 2011.
  17. Chin E and Otto K. investigation of a novel algorithm for true 4D-VMAT planning with comparison to tracked, gated and static delivery. Med Phys, 2011, 38, 2698-2707.
  18. Gete E, Teke T, Kwa W. Evaluation of the AAA Treatment Planning Algorithm for SBRT Lung Treatment: Comparison with Monte Carlo and Homogeneous Pencil Beam Dose Calculations. Journal of Medical Imaging and Radiation Sciences, 2011: doi:10.1016/j.jmir.2011.09.002

2011 Abstracts

  1. Herbert C, Moiseenko V, McKenzie M, Redekop G, Hsu F, Gete E, Gill B, Lee R, Luchka K. Predictive factors in the development of symptomatic radio necrosis following linear accelerator-based radiosurgery for arteriovenous malformations. International Journal of Radiation Oncology Biology Physics, 2011, 81, Supplement, p. S637
  2. Carlson RG, Morris WJ, Moiseenko V, Tyldesley S, Kosztyla R, Hamm J, Hui J, Jackson J, Sahota H, Liu M. The toxicity of dose escalated external beam radiation therapy after elective pelvic nodal irradiation: evaluating the utility of the QUANTEC rectal dose thresholds. International Journal of Radiation Oncology Biology Physics, 2011, 81, Supplement, p. S403
  3. Herbert C, Moiseenko V, McKenzie M, Redekop G, Hsu F, Gete E, Gill B, Lee R, Luchka K, Haw C, Lee A, Toyota B, Martin M. Linear accelerator-based stereotactic radiosurgery for intracerebral arteriovenous malformations: analysis of factors predictive of symptomatic radionecrosis. Radiotherapy and Oncology, 2011, 100, Supplement 1, p. S1
  4. Herbert C, Kwa W, Nakano S, James K, Moiseenko V, Wu J, Schellenberg D, Liu M. Stereotactic body radiotherapy: RapidArc versus 3-D non-coplanar conformal radiotherapy for the treatment of early stage lung cancer. Radiotherapy and Oncology, 2011, 100, Supplement 1, p. S12
  5. Follwell M, Morris J, Moiseenko V, Shaffer R, James K, Pickles T, Otto K. Volumetric modulated arc therapy for intraprostatic maximal simultaneous boost (IMAX): dosimetric analyses, safety and early clinical outcomes. Radiotherapy and Oncology, 2011, 100, Supplement 1, p. S46
  6. Karam I, Liu M, Vollans E, Vellani R, Zhang S, Wu J, Berthelet E, Moiseenko V. Intratumoral rapid arc boost using PET/CT delineation in non-small cell lung cancer. Radiotherapy and Oncology, 2011, 100, Supplement 1, p. S72
  7. Yin L, Liu M, Wu J, Shcherbinin S, Celler A, Duzenli C, Moiseenko V. Comparing regional perfusion loss in lung cancer patients treated with 3D conformal radiation therapy and stereotactic body radiation therapy. Medical Physics, 2011, 38, 3462
  8. Lee R, Liu M, Moiseenko V. A new metric to predict rectal bleeding based on dose-surface properties. Medical Physics, 2011, 38, 3493-3494
  9. Moiseenko V, LaPointe V, James K, Yin L, Liu M, Pawlicki T. Biological consequences of errors in MLC calibration in the context of IMRT delivery and QA. Medical Physics, 2011, 38, 3583
  10. Kosztyla R, Hsu F, Wilson D, Zhang S, Moiseenko V, Ma R, McKenzie M, Benard F, Nichol A. Interobserver volume variation in the target delineation of high grade gliomas using magnetic resonance imaging and 18-FDOPA positron emission tomography. Medical Physics, 2011, 38, 3832
  11. Lo A, Liu M, Chan E, Lund C, Loewen S, Cao J, Schellenberg D, Carolan H, Berrang T, Wu J, Dubash R, Kwan W, Berthelet E, Olson R. A Province-Wide Quality Assurance (QA) Review of Stereotactic Body Radiotherapy (SBRT) Treatment Planning for Lung Cancer.
  12. Chng N, Rasoda R, Spadinger I, Morris WJ, Salcudean T. Estimating Seed Orientation in Strands for Anisotropy Sensitive Post-implant Dosimetry of the Prostate. Brachytherapy, 2011, 10 (1) S66-S67.
  13. Keyes M, Pickles T, Spadinger I, Crook J, McKenzie M, Morris WJ. Multiple Organ Toxicities in 1006 Prostate Brachytherapy Patients with long-term follow-up. Brachytherapy, 2011, 10 (1) S81-S82.
  14. Herbert C, Morris WJ, Keyes M, Spadinger I, McKenzie M, Pickles T, Lapointe V, Hamm J. The Effect of Loose Seeds Versus Rapidstrand on Biochemical No Evidence of Recurrence (bNED) in Patients with prostate cancer treated with 125I Brachytherapy. Brachytherapy, 2011, 10 (1) S50.
  15. McParland N, Chng N, Keyes M, Morris J, Pickles T, McKenzie M, Wu J, Spadinger I. The Dosimetric Impact of Supplementing Pre-Planned Prostate Implants with Discretionary 125I seeds. Brachytherapy, 2011, 10 (1) S66.
  16. Herbert C, Morris WJ, Keyes M, Spadinger I, McKenzie M, Pickles T, Lapointe V, Hamm J. The Effect of Primary Gleason Pattern on Biochemical No Evidence of Disease (bNED) in patients with Gleason 7, localized prostate cancer treated with 125I Brachytherapy. Brachytherapy, 2011, 10 (1) S48-S49.
  17. Keyes M, Lapointe V, Pickles T, Crook J, Spadinger I, McKenzie M, Morris WJ. Radiation Oncologists Quality Assurance Program in British Columbia Cancer Agency Provincial Prostate Brachytherapy Program. Brachytherapy, 2011, 10 (1) S78.
  18. Hayden AJ, Keyes M, McKenzie M, Pickles T, Petrik D, Spadinger I, LaPointe V, Morris WJ. Erectile function following 125I Permanent Prostate Brachytherapy: 5-and 8-year Results in 1411 Men. Brachytherapy, 2011, 10 (1) S17.
  19. Chng N, Spadinger I, Morris WJ, Welsh M. An evaluation of Post-implant dosimetrics in simulated mixed activity LDR Prostate Brachytherapy Implants. Proc. Of the annual scientific meeting of the American Association of Physicists in Medicine, 2011.
  20. Chng N, Rasoda R, Spadinger I, Morris WJ, Salcudean S. Estimating Seed Orientation in Strands for Anisotropy Sensitive Post-Implant Dosimetry of the Prostate. Proc. Of the annual scientific meeting of the American Brachytherapy Society, 2011.
  21. J. Lucido, C. Yuen, M. Pearson, I. A. Popescu, “New CT-Based Planning Method for TBI Treatment”. Poster presented at the Joint AAPM/COMP Meeting, Vancouver, BC, Canada (August 2011).
  22. Kosztyla R, Hsu F, Wilson D, Zhang S, Moiseenko V, Ma R, McKenzie M, Benard F, Nichol A. WE-G-214-08: Interobserver volume variations in the target delineation of high-grade gliomas using magnetic resonance imaging and 18F-FDOPA positron emission tomography [Abstract]. Med Phys. 2011; 38(6):3832. (Paper presented at: 2011 Joint Meeting of the American Association of Physicists in Medicine and the Canadian Organization of Medical Physicists; 2011 July 31-Aug 4; Vancouver, BC.)
  23. Carlson RG, Morris WJ, Moiseenko V, Tyldesley S, Kosztyla R, Hamm J, Hui J, Jackson J, Sahota H, Liu M. The toxicity of dose escalated external beam radiation therapy after elective pelvic nodal irradiation: Evaluating the utility of the QUANTEC rectal dose thresholds [Abstract]. Int J Radiat Oncol Biol Phys. 2011; 81(2 Suppl.):S403. (Poster presented at: American Society for Radiation Oncology 53rd Annual Meeting; 2011 Oct 2-6; Miami Beach, FL.)
  24. Cropp R, Bergman A. Respiratory-correlated cone-beam CT for potential use in measuring lung tumor trajectory. Poster presentation, Abstract #15523, American Association of Physicists in Medicine Annual Meeting, (Vancouver, BC), July 2011.
  25. Cropp R, Bergman A. Respiratory-correlated (4D) cone-beam CT on Varian Linacs, Oral Presentation, Wescan (Abbotsford, BC), 2011.
  26. Caon J, Olson R, Tyldesley S, Bergman A, Bobinski M, Fong M, Ma V, Vellani R, Goddard K. Assessing the Risk of Accidental Exposure of Pregnant Patients to Ionizing Radiation during Radiation Therapy (RT) Planning and Treatment in British Columbia (BC). Canadian Association of Radiation Oncologists Annual Meeting, (Winnipeg, MN), 2011.
  27. Chin E, Otto K. Investigation of a new 4D VMAT Planning System with Comparison to 3D, Gating and Tracking VMAT Techniques. Young scientist oral poster competition. ESTRO 11th biennial, London, UK (May 2011).
  28. Chin E, Otto K. Optimizing Temporal Efficiency of 4D-Volumetric Modulated Arc Therapy. Oral presentation. AAPM/COMP, Vancouver, Canada (August 2011).
  29. Chin E, Otto K. 4D-Volumetric Modulated Arc Therapy. Webex presentation. CART Research and Education Seminar, UC San Diego (Dec 2011).
  30. Gete E. Treatment planning and Dosimetry of lung SBRT plans. Wescan 2011 Abbotsford, BC, April 2nd, 2011.
  31. Moiseenko V. Clinical implementation of Volumetric Modulated Arc for Conventionally Fractionated and Stereotactic Body Radiation Therapy. Plenary Speaker. April 19, 2011. 19th International Conference on Medical Physics (CMP) and XVI Brazilian Congress of Medical Physics, Porto Alegre, Brazil (17-20 April 2011).
  32. J. Lucido, V. Moiseenko, I. A. Popescu, “Comparison of track structure distributions generated by GEANT4-DNA and EGSnrc/NOREC for external beam radiation therapy using patient CT data”. Oral presentation at the International Workshop on Recent Advances in Monte Carlo Techniques for Radiation Therapy, Montreal, QC, Canada (June 2011).
  33. E. Heath, I. Badragan, I. A. Popescu, “4D Monte Carlo simulation of RapidArc delivery to a breathing patient using BEAMnrc/defDOSXYZnrc”. Oral presentation at the International Workshop on Recent Advances in Monte Carlo Techniques for Radiation Therapy, Montreal, QC, Canada (June 2011).
  34. R. Ottosson, A. R. Beierholm, C. E. Andersen, C. F. Behrens, I. A. Popescu, “Monte Carlo derived monitor backscatter and output factors using directional bremsstrahlung splitting”. Oral presentation at the European Society for Therapeutic Radiology and Oncology (ESTRO) Conference, London, UK (May, 2011).
  35. Y. Graves, X. Gu, X. Jia, T. Teke, I. A. Popescu, G. Kim, S. Jiang, “A Fast and Accurate GPU Based Patient-Specific RapidArc QA Package”. Oral presentation at the Joint AAPM/COMP Meeting, Vancouver, BC, Canada (August 2011).

2010 Publications

  1. Yin LS, Tang L, Hamarneh G, Gill B, Celler A, Shcherbinin S, Fua TF, Thompson A, Liu M, Duzenli C, Sheehan F and Moiseenko V. Complexity and accuracy of image registration methods in SPECT-guided radiation therapy. Phys Med Biol 55; 237-246, 2010
  2. Moiseenko V, Liu M, Bergman AM, Gill B, Kristensen S, Teke T, Popescu IA. Monte Carlo calculation of dose distribution in early stage NSCLC patients planned for accelerated hypofractionated radiation therapy in the NCIC-BR25 protocol. Phys Med Biol 55 (2010) 723-733
  3. JO Deasy, V Moiseenko, L Marks, KSC Chao, J Nam, A Eisbruch. Radiotherapy dose-volume effects on salivary gland function. International Journal of Radiation Oncology Biology Physics, 2010, 76, S58-S63
  4. R Shaffer, AN Nichol, E Vollans, M Fong, S Nakano, V Moiseenko, M Schmuland, R Ma, M McKenzie, K Otto. A comparison of volumetric modulated arc therapy and conventional intensity modulated radiotherapy for frontal and temporal high-grade gliomas. International Journal of Radiation Oncology Biology Physics, 2010, 76, 1177-1184
  5. G Gagliardi, LS Constine, V Moiseenko, C Correa, LJ Pierce, AM Allen, LB Marks. Radiation dose-volume effects in the heart. International Journal of Radiation Oncology Biology Physics, 2010, 76, S77-S85
  6. L Yin, S Shcherbinin, A Celler, A Thompson, T-F Fua, M Liu, C Duzenli, B Gill, F Sheehan, J Powe, D Worsley, L Marks, V Moiseenko. Incorporating Quantitative SPECT into Radiation Therapy Treatment Planning for Lung Cancer: The Impact of Attenuation and Scatter Correction on the SPECT Weighted Mean Dose and Functional Lung Segmentation. International Journal of Radition Oncology Biology Physics (in press)
  7. Shaffer R, Vollans E, Vellani R, Welsh M, Moiseenko V, Goddard K. A radiotherapy planning study of RapidArc, intensity modulated radiotherapy, three-dimensional conformal radiotherapy and parallel opposed beams in the treatment of pediatric retroperitoneal tumors. Pediatric Blood & Cancer
  8. R Shaffer, T Pickles, R Lee, V Moiseenko. Deriving prostate alpha-beta ratio using carefully matched groups, long follow-up and the Phoenix definition of biochemical failure. International Journal of Radition Oncology Biology Physics (in press)
  9. T. Teke, A. Bergman, W. Kwa, B. Gill, C. Duzenli, I. A. Popescu. Monte Carlo based, patient-specific RapidArc QA using Linac log files. Med. Phys. 37 (2010) 116-23.

2009 Publications

  1. Mestrovic A, Nichol A, Clark BG, Otto K. Integration of on-line imaging, plan adaptation and radiation delivery: proof of concept using digital tomosynthesis. Phys Med Biol. 2009 Jun 21;54(12):3803-19.
  2. R Shaffer, A M Nichol, E Vollans, M Fong, S Nakano, V Moiseenko, M Schmuland, R Ma, M McKenzie, K Otto. A Comparison of Volumetric Modulated Arc Therapy and Conventional Intensity-Modulated Radiotherapy for Frontal and Temporal High-Grade Gliomas. Int. J. Radiation Oncology Biol. Phys. 2010; 76(4):1177-1184.
  3. R Shaffer, W J Morris, V Moiseenko, M Welsh, C Crumley, S Nakano, M Schmuland, T Pickles, K Otto. Volumetric Modulated Arc Therapy (VMAT) and Conventional Intensity Modulated Radiotherapy for Simultaneous Maximal Intra-prostatic Boost: A Planning Comparison Study. Clinical Oncology 2009; 21:401-407.
  4. Keyes M, Miller S, Moravan V, Pickles T, Liu M, Spadinger I, Lapointe V, Morris WJ. Urinary Symptom Flare in 712 (125)I prostate brachytherapy patients: Long-Term Follow-Up. Int J Radiat Oncol Biol Phys. 2009;75:649-55.
  5. Morris WJ, Keyes M, Palma D, Spadinger I, McKenzie MR, Agranovich A, Pickles T, Liu M, Kwan W, Wu J, Berthelet E, Pai H. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer. Urology. 2009;73:860-5.
  6. Keyes M, Miller S, Moravan V, Pickles T, McKenzie M, Pai H, Liu M, Kwan W, Agranovich A, Spadinger I, Lapointe V, Halperin R, Morris WJ. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients. Int J Radiat Oncol Biol Phys. 2009;73:1023-32.
  7. Morris, WJ, Keyes M, Palma D, McKenzie M, Spadinger I, Agranovich A, Pickles T, Liu M, Kwan W, Wu J, Lapointe V, Berthelet E, Pai H, Harrison R, Kwa W, Bucci J, Racz V, Woods R. Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009;73:1432-8.